400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2021-05-26
NiKang Therapeutics Inc
创新的小分子肿瘤药物研发商
医药研发/制造
化学&生物药
Casdin Capital;
Casdin Capital;
EcoR1 Capital;
EcoR1 Capital;
Janus Henderson Investors;
RTW Investments;
RA Capital;
PFM Health Sciences;
Pavilion Capital;
Surveyor Capital;
Samsara BioCapital;
Logos Capital;
HBM Healthcare;
BlackRock;
Perceptive Advisors;
Invus;
鱼鹰资管;
Wellington Management;
汇桥资本;
Octagon Investments Master Fund
2020-09-14
NiKang Therapeutics Inc
创新的小分子肿瘤药物研发商
医药研发/制造
化学&生物药
中国农药工业协会2026-01-26
经纬创投2026-01-26
GMP办公室2026-01-26
功能与专用化学品2026-01-26
一度医药2026-01-26
细胞与基因治疗领域2026-01-26
同写意2026-01-26
CIO合规保证组织2026-01-26
德联资本2026-01-26
生物安全情报网2026-01-26